While the unit !apart of the VAMC, it operates in many ways as an arm of the Central Office Rehab R&D Service.
Technology has much to offer the physically or sensorially impaired veteran in overcoming the handicaps that disabilities and environmental barriers may cause . But successful technology applications require both creative research and deve!opmmnt and effective production and distribution . To discuss evaluation, it is necessary to consider itaro!nina!! phases of this complex process.
The basic function of the VA Rehab R&D Evaluation Unit is to assist the VA Rehab R&D Service in its prime role of making effective devices and techniques available to veterans --each of whom is unique in the nature of his disability and personal desires . The unit will concentrate on evaluation as one of the major elements in the research, development, production, and distribution process . Its activities and relationships are analyzed in the schematic diagram ( Fig . ' What accompanies this writing, Autheendof1984approached, tkeVeterans Adminio' 1ration'anewRehabR&DEvuiuetionUnithada!readyotarteU to mobilize personnel, assets, and resources for the evaluation of nine devices and an animal aide concept . In some of the projects involving devices, prototypes were already in production in quantities required for clinical field testing. Table 1 lists the year-end lineup and status of the Evaluation Unit's work.
The role of the new VA Rehab R&D Evaluation Unit in the evaluation process is well illustrated by the case of the VA Seattle Foot . This new prosthetic foot was de-*eloped by Dr . Ernest Burgess, Director of the Prosthetic Research Study at the &4Medical Center inSeattle, VVaah' inA1on .xviththemnsin!anoeofanengineerwhoiofamihar with contemporary advances in materials technology . The result of their collaboration is a prosthetic foot that employs a plastic keel (really a kind of leaf spring) embedded in a cosmetic foam foot . The keel deflects with the foot under load, storing the amputee's stance energy, and then returns that energy when the amputee steps off his foot, giving himanot!ueab!e^puoh^ TheaoUoniaeomevvhat!ike1hat of the intact Achilles Tendon . Amputees report improved and quicker gait and increased agility in sport activities.
The VA-Seattle Foot evaluation is the farthest along of the Evaluation Unit's current projects, and the highlights of this evaluation (summarized below) provide some insight into the creativeness and complexity that are involved in orchestrating such a program on the scale necessary for even a relatively simple device.
How the VA/Seattle Foot is being moved through a nationwide evaluation program in VA Centers 1. The long-established Prosthetic Research Study (PR of the VA Medical Center in Seattle, Washington, obtaine "small" private firm, to assist in design and fabri first 50 fex -hose feet were fitted by the PRS /r subjects . A preliminary in-house eve!ual n tde by Dr . Burgess and staff.
2. On the basis of the encouraging results of Burgess' group's evaluation, the VA Rehabilitation R&D Service initiated aoontraot with MIW to produce 500 of the feet for clinical evaluation.
3. The VA's Rehab R&D Evaluation Unit and the VA's Prosthetic & Sensory Aid Service (PSAS) joined in a collaborative management plan . PSAS designated the 44 Prosthetic Services (in VA KAedioa! Centers throughout the nation) to participate . Instructions for subject selection and for ordering feet, and the protocols for evaluation, were jointly formulated and promulgated to each 44 centers.
4. All requests for feet, the subject data recort ._ completed evaluation forms are being processe Rehab R&D Evaluation Unit, where data are entered intc computer. Orders then are transmitted to MIW which shi the feet directly to prosthetic contractors serving t VAMC Prosthetic Clinics,
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Evaluation data are then analyzed by both the Rehab R&D Evaluation Unit and the Prosthetic Research Study in Seattle.
5. Six (6) feet were sent to the U .S . Army Research & Development Center at Natick, Massachusetts . Through an interagency agreement, Natick is life-testing these feet on a special "walking machine" originally designed to simulate normal gait for testing shoes.
6. The Rehab R&D Evaluation Unit is responsible for the preparation of the final report .
That six-point overview illustrates the way an effective evaluation process may be accomplished within the VA system, using a relatively small unit to act as a center of management and coordination to synergize substantial resources already in place throughout the system . The result is that a significant number of veterans are provided with an improved device, a new device is brought into production and distribution by a private firm, and extensive objective and subjective evaluation data are produced, analyzed, and published m
From monitoring research-in-progress to helping manufacturers get into production p the VA's new Evaluation Unit will help with the critical decisions.
Because the evaluation process as it is understood in the VA's new Evaluation Unit is a dynamic process, it can best be described with the aid of aflow ohart .Thefollowing description is divided into paragraphs labeled [A] through [H] , each of which focuses on aaimi\ar!y labeled point in Figure 1 which is, in essence, a flow chart.
[A] The VA Rehab R&D Service, assisted by a Scientific Merit Review Board, determines each year its major priority areas for R&D funding . As of this writing, there are three : (i) Sensory Aids for blind and visuaRy impaired and deaf and hearing impaired veterans ; ( ii ) Orthotic and Prosthetic devices for physically impaired veterans; and (iii) Functional Electrical Stimulation systems that promise to someday make paralyzed veterans mobile on their own legs. The Rehab R&D Evaluation Unit assists the Rehab R&D Service in its selection of R&D projects that are most likely to produce results.
[B] Monitoring programs and projects is a vital function of the Rehab R&D Service . The teuhnioal and administrative staff of the Evaluation Unit assists the staff of the Service as a natural part of its responsibility to be aware, in detail, of the technical activity in projects as it prepares for evaluation of developed devices that result from those projects.
IC] Internal Test and Evaluation is a critical part of the development process . Any new deviPe must be tested for funoUnn, reliability, and safety before it may be used . If used by or on a human being, the study and human-subject forms will require approval by an Institutional Review Board and may require FDA clearance for experimental study . The inescapable fact is that not until the device is first tried on aoubieot (in uclinical or home environment) will the specifications for the device become really clear and the defects become apparent . For one or both of these reasons, the first prototype will be returned to the research and development groupforredeeignand improvement--and it is seldom that only one cycle in this loop is enough. Rather, the process becomes a continuous one, with new and improved models being worked on and evaluated and each, in turn, contributing its share to the flow of data. The Rehab R&D Evaluation Unit intends to stay close to these internal evaluations -assisting in the design of protocols, facilitating FDA clearances, and helping to decide when performance is sufficient to consider moving the device to private industry.
ID] "D" represents the first critical "decision switch ." It is often difficult for a developer to accept the freezing of his design for production at a time when he is still working on various improved versions . But at some point, adecioion that a device has attained a (ewel of development sufficient for design of a production model must be made . The decision wili usually be u]oint one, involving the developer, the Rehab R&D Service, and a potential manufacturer . The Unit will serve as a facilitator and advisor to the Service in making this decision.
1E) Production Design and
Tooling is principally the responsibility of a manufacturer, but very close liaison with the developer and the Service is important and usually desired by the firm . In some cases, it will be appropriate and desirable for the Service to provide financial incentive, usually in the form of an initial purchase orderof units for evaluation . When the potential market is uncertain, as it often is, this may be the only way a company responsible to its stockholders can launch such a project . Other forms of support, especially forama!!buainmaoea,maybmfeciUietedfnomcther federal agencies . In the case of use by the VA, waivers of liability may be provided . (The high cost of liability protection often deters a ama!l firm .) The Evaluation Unit will assist the Rehab R&D Service in this process.
[ evaluations in locations throughout the nation or even worldwide . Most such activities will occur within the Veterans Administration Medical Center system, but when unique resources are required and can be identified outside the system, they will be employed . Effective evaluations are vital to a manufacturer anticipating full-scale production, since only in this way can acompany beeunai1apnoduc1wi!!mem1area!nmed . In addition, the indications for the prescription and use of the device will be defined, and information will be developed for training practitioners and third-party payers in its application . Assistance with FDA premarket clearances may also be provided, as well as waivers of liability for use in the VA system, as mentioned earlier.
[G] The second "decision switch" determines whether to return the production prototype to redesign, or to terminate the pn4eot, or to proceed with full-scale production and distribution . While this must be a decision of the manufacturer, the Rehab R&D Service and the Rehab R&D Evaluation Unit will provide assistance .
[H] When the manufacturer decides to produce and market the device, he will look to the VA and the civilian sector for sales . In the case of the VA, his commercial product will come under the cognizance of the VA Prosthetics and Sensory Aids Service, which has the responsibility to evaluate the product before declaring it safe and cost-effective for purchase and use in the VA system.
The Rehab R&D Evaluation Unit is y oung and its staff members are few-but the need for it is great . It plans to grow gradually, taking on more and larger tasks until it attains the capability to serve the needs of the entire VA system. But, the needs of the nation's veterans are not unique and at present there is no coordinated evaluation capability throughout the country . It is hoped that the form and productivity of the new Evaluation Unit will serve as a model for a truly national system that can help developers and manufacturers to better serve all handicapped persons 
